Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

The Phase 3 AMPLITUDE trial led by UCL found that adding the PARP inhibitor niraparib to standard hormone therapy may slow ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Zosia Miedzybrodzka has been appointed an Officer of the Order of the British Empire (OBE) for her services to genetics ...

RAD51-based assessment effectively identifies HER2-negative metastatic breast cancer patients likely to respond to olaparib, especially with BRCA1/2 or PALB2 variants. RAD51-low tumors showed a higher ...

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

Sir Cliff Richard has revealed he has been treated for prostate cancer. In an interview on ITV's Good Morning Britain, the 85-year-old singer revealed that his cancer had "gone at the moment". Get the ...

Cedars Sinai gets 30M to establish a specialized BRCA cancer center focusing on research, diagnosis, and treatment in Los Angeles.

Much like finding a single sock missing after laundry day, it is easy for men to overlook the possibility of breast cancer, ...

A new ICMR study finds breast cancer among the top three cancers affecting Indian women, linking higher risk to age, obesity, ...